Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas

Modern Pathology

Volumn 22, Issue 8, 2009, Pages 1016-1022

  Martignoni, G ^a   Pea, M ^b   Gobbo, S ^a   Brunelli, M ^a   Bonetti, F ^a   Segala, D ^a   Pan, Chin Chen ^c   Netto, G ^d   Doglioni, C ^e   Hes, O ^f   Argani, P ^d   Chilosi, M ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Anatomia Patologica   (Italy)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cathepsin K; Immunohistochemistry; Renal cell carcinoma; TFE3; TFEB; Translocation

Indexed keywords

CATHEPSIN K; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E3; TRANSCRIPTION FACTOR EB; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPL GENE; CHILD; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FUSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MALE; ONCOCYTOMA; PRCC GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSF GENE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CATHEPSINS; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; TISSUE ARRAY ANALYSIS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 68249127067     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.58     Document Type: Article

References (21)

1. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001;159:179-192.
2. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol 2001;158:2089-2096.
3. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 2002;26:1553-1566.
4. Clark J, Lu YJ, Sidhar SK, et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 1997;15:2233-2239.
5. Argani P, Lae M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 2005;29:230-240.
6. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohisto-chemical assay. Am J Surg Pathol 2003;27:750-761.
7. Fisher DE, Carr CS, Parent LA, et al. TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family. Genes Dev 1991;5:2342-2352.
8. Hemesath TJ, Steingrimsson E, McGill G, et al. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 1994;8:2770-2780.
9. Kuiper RP, Schepens M, Thijssen J, et al. Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains. Nucleic Acids Res 2004;32: 2315-2322.
10. Zhao GQ, Zhao Q, Zhou X, et al. TFEC, a basic helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation. Mol Cell Biol 1993;13:4505-4512.
11. Motyckova G, Weilbaecher KN, Horstmann M, et al. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci USA 2001;98:5798-5803.
12. Argani P, Lae M, Ballard ET, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol 2006;24:1529-1534.
13. Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 2007;31:1149-1160.
14. Onder AM, Teomete U, Argani P, et al. PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma. Pediatr Nephrol 2006;21:1471-1475.
15. Parast MM, Eudy G, Gow KW, et al. A unique case of renal carcinoma with Xp11.2 translocations/TFE3 gene fusions in a 3-year-old child, with coexistent von Hippel-Lindau gene mutation. Pediatr Dev Pathol 2004;7:403-406.
16. Pecciarini L, Cangi MG, Lo Cunsolo C, et al. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient. Genes Chromosomes Cancer 2007; 46:419-426.
17. Perot C, Boccon-Gibod L, Bouvier R, et al. Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic study. Cancer Genet Cytogenet 2003;143:93-99.
18. Chilosi M, Poletti V, Zamo A, et al. Aberrant Wnt/betacatenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003;162:1495-1502.
19. Zhong M, Habermann J, Andraws N, et al. Xp11.2 translocation renal cell carcinoma (RCC) in adults A TMA study of 120 RCC cases. Mod Pathol 2009;203A.
20. Mosquera JM, Dal Cin P, Mertz KD, et al. Validation of a TFE3 break-apart FISH assay in Xp11.2 translocation renal cell carcinomas. Mod Pathol 2008;172A.
21. Lae M, Argani P, Olshen A, et al. Global gene expression profiles of renal carcinomas with Xp11 translocations (TFE3 gene fusions) suggest a closer relationship to alveolar soft part sarcomas than to adult type renal cell carcinomas. Mod Pathol 2004;163A.